GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of why does nobody talk about EU — 48 comments in the full submission. View in context.
1.2k
c/glp1eu·submitted 11 months ago by u/cormac_erdogan

why does nobody talk about EU

Questionbranch of 11 comments

why does nobody talk about EU. If this has been answered properly somewhere, link me and I will delete. On cross-border prescriptions, since the assumption behind half these threads is wrong. There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the…

Read the full submission and all 48 comments →

This branch

11 comments, started 11 months ago
u/naomi_erdogan61 points·11 months ago

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

replysharereportpermalink
u/joaquin_trevino15 points·11 months ago

private pricing varies enormously between neighbouring countries

replysharereportpermalink
u/vikram_asante22 points·11 months ago

a prescription from one member state is not automatically valid in another

replysharereportpermalink
u/cormac_erdoganOP17 points·11 months ago

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

replysharereportpermalink
u/tove_ogunleye23 points·11 months ago

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
u/nl_verzekering14 points·11 months ago

Disagree.

tove_ogunleye is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/TitrationTortoiseslow and boring4 points·11 months ago

the EMA authorises, member states decide who pays

replysharereportpermalink
u/tobias_vukovic1 point·11 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/cormac_erdoganOP0 points·11 months ago

Have you read the published reimbursement criteria where you are?

replysharereportpermalink
u/jarno_karlsen1 point·11 months ago

Have you read the published reimbursement criteria where you are?

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

replysharereportpermalink
u/fabio_nkemelu1 point·11 months ago

Which member state?

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.